Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,286,475
New position
Shares Held
414,959
first reported quarter
Ownership
0.228%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 238 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 83%
None 17%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jupiter Topco LLC holds $1,861,043,640 across 27 Drug Manufacturers - Specialty & Generic names. XERS ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
5,188,416 | $575,602,868 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
831,129 | $450,330,624 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,954,629 | $167,862,830 | |
| 4 | ZTS |
Zoetis Inc.
|
1,937,891 | $139,256,846 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
9,540,764 | $95,407,640 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
5,236,102 | $94,040,391 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
526,341 | $88,709,511 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
2,147,072 | $77,724,006 |
All Filings in XERS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,286,475 | 414,959 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||